The Impact of Inflammatory Markers and Obesity in Chronic Venous Disease

被引:2
|
作者
Petrascu, Flavia-Medana [1 ,2 ]
Matei, Sergiu-Ciprian [3 ,4 ]
Margan, Madalin-Marius [5 ,6 ]
Ungureanu, Ana-Maria [7 ]
Olteanu, Gheorghe-Emilian [1 ,8 ,9 ]
Murariu, Marius-Sorin [3 ,4 ]
Olariu, Sorin [3 ,4 ]
Marian, Catalin [1 ,2 ,10 ]
机构
[1] Victor Babes Univ Med, Dept Doctoral Studies & Pharm, Timisoara 300041, Romania
[2] Victor Babes Univ Med & Pharm, Dept Biochem, Timisoara 300041, Romania
[3] Victor Babes Univ Med & Pharm, Abdominal Surg & Phlebol Res Ctr, Timisoara 300041, Romania
[4] Pius Brinzeu Emergency Cty Hosp, Surg Dept 1, Timisoara 300723, Romania
[5] Victor Babes Univ Med & Pharm, Dept Funct Sci, Discipline Publ Hlth, Timisoara 300041, Romania
[6] Victor Babes Univ Med & Pharm, Fac Med, Ctr Translat Res & Syst Med, Timisoara 300041, Romania
[7] Victor Babes Univ Med & Pharm, Dept Radiol & Med Imaging, Timisoara 300041, Romania
[8] Victor Babes Univ Med & Pharm, Fac Pharm, Res Ctr Pharmaco Toxicol Evaluat, Timisoara 300041, Romania
[9] Victor Babes Univ Med & Pharm, Ctr Res & Innovat Personalized Med Resp Dis, Timisoara 300041, Romania
[10] Victor Babes Univ Med & Pharm, Ctr Complex Networks Sci, Timisoara 300041, Romania
关键词
obesity; inflammation; chronic venous disease; endothelial dysfunction; microcirculatory damage; C-REACTIVE PROTEIN; INSUFFICIENCY; MANAGEMENT; COMPRESSION; DISORDERS;
D O I
10.3390/biomedicines12112524
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Chronic venous disease (CVD) represents a significant health challenge, particularly in obese individuals. This study focuses on the interplay between inflammation, obesity, and CVD, by analyzing the role of inflammatory markers in the disease progression. Methods: Clinical and paraclinical data of 619 patients hospitalized and treated in the Phlebology Department (1stSurgical Department, "Pius Br & icirc;nzeu" Emergency County Hospital Timisoara, Romania) between 2018 and 2024 were analyzed. Results: The statistical analysis revealed that age, C-reactive protein (CRP), fibrinogen, and absolute neutrophil count (ANC) were key predictors of CVD progression. Specifically, elevated CRP and fibrinogen levels correlated strongly with increased CVD severity, particularly in patients with higher body-mass index (BMI). BMI, while not an independent predictor, contributed indirectly to the disease severity through its association with these inflammatory markers. The logistic regression model incorporating age, BMI, CRP, fibrinogen, and ANC demonstrated a high predictive accuracy, with an area under the curve (AUC) of 0.902, highlighting the models reliability in stratifying patients at risk for severe CVD. Conclusions: This predictive model not only aids in identifying high-risk patients but also reinforces inflammation as a critical therapeutic target in CVD management.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Relationship between inflammatory markers and infection in chronic kidney disease
    Sipahi, Sultan Naza
    Kir, Seher
    Dilek, Melda
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (01): : 177 - 185
  • [22] Insulin Resistance & Inflammatory Markers in Obesity
    Bhatty, Shaheen Ayoob
    Aziz, Sina
    Shaikh, Niaz A.
    Hussain, Tahir
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (01) : 101 - 104
  • [23] Obesity and worsening of chronic venous disease and joint mobility
    Quilici Belczak, Cleusa Ema
    Pereira de Godoy, Jose Maria
    Belzack, Sergio Quilici
    Ramos, Rubiana Neves
    Caffaro, Roberto Augusto
    PHLEBOLOGY, 2014, 29 (08) : 500 - 504
  • [24] Chronic Venous Disease in the new times. Venocheck Proposal
    Ramirez Torres, J. M.
    Caballer Rodilla, J.
    Frias Vargas, M.
    Garcia Vallejo, O.
    Gil Gil, I
    MEDICINA DE FAMILIA-SEMERGEN, 2022, 48 (05): : 344 - 355
  • [25] The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives
    Santiago, Fabricio Rodrigues
    Ulloa, Jorge
    Regnier, Catherine
    Peudon, Thibault
    Braund, Emilie
    Fradet-Aubignat, Claire
    Gianesini, Sergio
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (11) : 789 - 803
  • [26] Risk factors for chronic venous disease
    Vlajinac, H. D.
    Radak, D. J.
    Marinkovic, J. M.
    Maksimovic, M. Z.
    PHLEBOLOGY, 2012, 27 (08) : 416 - 422
  • [27] Varicose Veins and Chronic Venous Disease
    Alsaigh, Tom
    Fukaya, Eri
    CARDIOLOGY CLINICS, 2021, 39 (04) : 567 - 581
  • [28] Burden and Suffering in Chronic Venous Disease
    Nicolaides, Andrew N.
    Labropoulos, Nicos
    ADVANCES IN THERAPY, 2019, 36 (Suppl 1) : 1 - 4
  • [29] Impact of statin treatment on patients diagnosed with chronic venous disease. Morphological analysis of the venous wall and clinical implications
    Matei, Sergiu-Ciprian
    Matei, Mervat
    Anghel, Flavia Medana
    Derban, Mihnea Dragos
    Olariu, Andra
    Olariu, Sorin
    PHLEBOLOGY, 2022, 37 (03) : 188 - 195
  • [30] Estrogen Receptors and Chronic Venous Disease
    Serra, R.
    Gallelli, L.
    Perri, P.
    De Francesco, E. M.
    Rigiracciolo, D. C.
    Mastroroberto, P.
    Maggiolini, M.
    de Franciscis, S.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2016, 52 (01) : 114 - 118